EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Underdiagnosis of Alpha‐1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study

Manon Evain iD, Isaac Ruiz iD, Teresa Antonini, Guillaume Lassailly, Alessandra Mazzola, Pauline Houssel Debry, Laure Elkrief, Rodolphe Anty, Mylène Sebagh, Philippe Ichai, Daniel Cherqui, Didier Samuel und 3 weitere

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.70183 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Manon Evain und 14 weiteren Autor:innen. Beteiligte Einrichtung: AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, Paris-Saclay University, Villejuif, France. Hauptthemen laut MEDLINE: alpha 1-Antitrypsin Deficiency, Liver Transplantation, Liver Cirrhosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Alpha‐1 antitrypsin deficiency (AATD) is a prevalent genetic disorder in Europe causing hepatic fibrosis and often remains undiagnosed, even in severe cases requiring liver transplantation (LT). This study aimed to determine the frequency of pre‐LT diagnosis amongst LT candidates with AATD and to describe their clinical characteristics. A secondary goal was to assess awareness and practices concerning AATD amongst LT specialists in France.

Methods

This retrospective multicenter cohort study included LT candidates diagnosed with AATD based on PAS‐positive staining of explanted livers (1995–2020) from nine centres in France and Canada. A 22‐question survey was sent to LT specialists in France to assess AATD knowledge and practices.

Results

Amongst 58 patients diagnosed with AATD between 1996 and 2020, 40% were diagnosed pre‐LT, 15% post‐LT and 45% never confirmed. Less than 25% had non‐specific pulmonary symptoms. The survey revealed poor awareness of AATD; 78% of specialists rated their knowledge as very low to moderate. Consistent pre‐LT screening occurred in 59.3% of cases, and 52.5% recommended familial screening upon a confirmed diagnosis.

Conclusion

AATD remains underdiagnosed in pre‐LT assessments and is poorly understood amongst practitioners in France. Improved screening can enhance patient management, especially with emerging potentially curative treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha 1-Antitrypsin DeficiencyLiver TransplantationLiver CirrhosisHumansRetrospective StudiesMaleFemaleMiddle AgedFranceAdultCanadaAgedSurveys and Questionnaires

Stichwörter der Autor:innen

alpha‐1 antitrypsingeneticliver transplantationsurvey

Autor:innen und Institutionen

  • AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, Paris-Saclay University, Villejuif, France.
  • Department of Hepatology and Liver Transplantation, Centre Hospitalier de l'Universite of Montréal, Montreal, Canada.
  • The Lyon liver institute, Everest IHU, Hepatology Department, Croix Rousse Hospital, Hospices Civils of Lyon, Lyon, France, Lyon, France.
  • Service des Maladies de l'Appareil Digestif, Centre Hospitalier Universitaire de Lille (CHU de Lille), Lille, France; European Genomic Institute for Diabetes (EGID), UMR 1190 Translational Research for Diabetes, Inserm,…
  • Service d'hépato-gastroentérologie, Hôpital La Pitié Salpêtrière, Paris, France.
  • Service des maladies du foie, CHU Rennes, France.

ORCID-Profile: Manon Evain, Isaac Ruiz

Zitieren

APA

Evain, M., Ruiz, I., Antonini, T., Lassailly, G., Mazzola, A., Debry, P. H., Elkrief, L., Anty, R., Sebagh, M., Ichai, P., Cherqui, D., Samuel, D., Kounis, I., Coilly, A., & GREF 2 group (2025). Underdiagnosis of Alpha‐1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70183

Vancouver

Evain M, Ruiz I, Antonini T, Lassailly G, Mazzola A, Debry PH, et al. Underdiagnosis of Alpha‐1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.70183

BibTeX
@article{Evain2025,
  author = {Evain, Manon and Ruiz, Isaac and Antonini, Teresa and Lassailly, Guillaume and Mazzola, Alessandra and Debry, Pauline Houssel and Elkrief, Laure and Anty, Rodolphe and Sebagh, Mylène and Ichai, Philippe and Cherqui, Daniel and Samuel, Didier and Kounis, Ilias and Coilly, Audrey and GREF 2 group, GREF 2 group},
  title = {Underdiagnosis of Alpha‐1 Antitrypsin Deficiency in Cirrhotic Liver Transplant Candidates: Findings From a Multicenter Retrospective Study},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.70183}
}
Kostenlos starten →